Total Payments
$6,505
2024 Payments
$876.30
Companies
30
Transactions
411
Medicare Patients
8,749
Medicare Billing
$972,098
Payment Breakdown by Category
Food & Beverage$6,383 (98.1%)
Education$121.65 (1.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,383 | 406 | 98.1% |
| Education | $121.65 | 5 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,368 | 69 | $0 (2024) |
| Novo Nordisk Inc | $1,084 | 81 | $0 (2024) |
| Amgen Inc. | $565.16 | 41 | $0 (2024) |
| ABBVIE INC. | $431.56 | 24 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $429.71 | 29 | $0 (2022) |
| PFIZER INC. | $378.82 | 28 | $0 (2024) |
| Astellas Pharma US Inc | $375.35 | 20 | $0 (2022) |
| Lilly USA, LLC | $344.41 | 25 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $281.24 | 21 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $180.68 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $876.30 | 41 | AstraZeneca Pharmaceuticals LP ($304.91) |
| 2023 | $490.13 | 25 | AstraZeneca Pharmaceuticals LP ($162.31) |
| 2022 | $545.49 | 35 | AstraZeneca Pharmaceuticals LP ($163.87) |
| 2021 | $826.22 | 60 | Novo Nordisk Inc ($225.06) |
| 2020 | $764.86 | 55 | Novo Nordisk Inc ($213.01) |
| 2019 | $959.15 | 64 | Novo Nordisk Inc ($278.95) |
| 2018 | $868.95 | 60 | Novo Nordisk Inc ($157.66) |
| 2017 | $1,174 | 71 | Janssen Pharmaceuticals, Inc ($305.67) |
All Payment Transactions
411 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Oncology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Diabetes Care | ||||||
| 09/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Cardiology | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Diabetes | ||||||
| 09/20/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Oncology | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Respiratory | ||||||
| 08/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Oncology | ||||||
| 07/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2024 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Cardio-renal | ||||||
| 06/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Cardio-renal | ||||||
| 05/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,622 | 4,166 | $511,850 | $290,305 |
| 2022 | 25 | 2,821 | 4,267 | $528,189 | $307,245 |
| 2021 | 22 | 2,159 | 3,231 | $403,824 | $242,111 |
| 2020 | 17 | 1,147 | 1,826 | $255,915 | $132,437 |
Total Patients
8,749
Total Services
13,490
Medicare Billing
$972,098
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 310 | 672 | $116,928 | $68,383 | 58.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 110 | 833 | $90,797 | $53,045 | 58.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 255 | 255 | $47,685 | $36,529 | 76.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 192 | 346 | $40,828 | $25,086 | 61.4% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 28 | 293 | $39,262 | $17,660 | 45.0% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 98 | 112 | $29,456 | $17,434 | 59.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 246 | 247 | $39,520 | $16,743 | 42.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 30 | 39 | $20,163 | $9,518 | 47.2% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 266 | 266 | $13,300 | $7,538 | 56.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 266 | 266 | $11,970 | $5,581 | 46.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 255 | 255 | $11,475 | $5,350 | 46.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 67 | 67 | $5,762 | $5,079 | 88.2% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 15 | 16 | $8,272 | $3,651 | 44.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $7,260 | $3,537 | 48.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 22 | $5,126 | $3,471 | 67.7% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 91 | 91 | $6,825 | $2,543 | 37.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 71 | 71 | $2,911 | $2,412 | 82.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 40 | 48 | $3,600 | $2,390 | 66.4% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 104 | 105 | $2,415 | $1,710 | 70.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 111 | 115 | $3,795 | $1,477 | 38.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 23 | 25 | $4,500 | $1,167 | 25.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 328 | 729 | $126,846 | $75,292 | 59.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 102 | 770 | $83,930 | $46,738 | 55.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 270 | 270 | $50,490 | $40,183 | 79.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 186 | 319 | $37,642 | $24,231 | 64.4% |
About Dr. Lisa Li, DO
Dr. Lisa Li, DO is a Internal Medicine healthcare provider based in Succasunna, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851326151.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lisa Li, DO has received a total of $6,505 in payments from pharmaceutical and medical device companies, with $876.30 received in 2024. These payments were reported across 411 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($6,383).
As a Medicare-enrolled provider, Li has provided services to 8,749 Medicare beneficiaries, totaling 13,490 services with total Medicare billing of $972,098. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Succasunna, NJ
- Active Since 07/12/2006
- Last Updated 03/13/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1851326151
Products in Payments
- FARXIGA (Drug) $893.71
- Ozempic (Drug) $582.04
- LOKELMA (Drug) $292.93
- UBRELVY (Drug) $265.84
- Prolia (Biological) $258.29
- XARELTO (Drug) $232.79
- Tresiba (Drug) $220.83
- JARDIANCE (Drug) $201.68
- INVOKANA (Drug) $190.90
- Kerendia (Drug) $180.68
- JANUVIA (Drug) $179.09
- COLOGUARD (Device) $172.60
- EVENITY (Biological) $172.15
- Livalo (Drug) $154.57
- Cologuard Collection Kit (Device) $148.70
- Myrbetriq (Drug) $134.07
- Equinoxe (Device) $121.00
- TRULICITY (Drug) $117.11
- Victoza (Drug) $116.41
- MYRBETRIQ (Drug) $84.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.